Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 37.11% is 25% below its 3-year average of 49.57%, around the middle of its 3-year range (1.08%–60.01%).
As of the fiscal period ended Tuesday, June 30, 2026. 5.80% below its 12-month average of 39.40%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 37.11%.
DEBT TO ASSETS RATIO
37.11%
DEBT TO ASSETS RATIO AVG TTM
39.40%
DEBT TO ASSETS RATIO AVG 3Y
49.57%
DEBT TO ASSETS RATIO AVG 5Y
N/A
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-5.80%
CURRENT VS 3Y AVG
-25.13%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.29%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+12922.09%
vs the sector median at left
Solventum Corporation
Market Cap
$15.51B
Debt to Assets Ratio
37.11%
TTM Avg
39.40%
3Y Avg
49.57%
5Y Avg
N/A
Market Cap
$16.19B
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.13B
Debt to Assets Ratio
0.40%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$17.99B
Debt to Assets Ratio
0.33%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.45B
Debt to Assets Ratio
0.49%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.11B
Debt to Assets Ratio
0.38%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solventum Corporation (SOLV) | $15.51B | 37.11% | 39.40% | 49.57% | N/A |
| Medpace Holdings, Inc. (MEDP)vs › | $16.19B | 0.06% | N/A | N/A | N/A |
| Exelixis, Inc. (EXEL)vs › | $14.59B | 0.07% | N/A | N/A | N/A |
| Revvity, Inc. (RVTY)vs › | $13.58B | 0.28% | N/A | N/A | N/A |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.13B | 0.40% | N/A | N/A | N/A |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $17.99B | 0.33% | N/A | N/A | N/A |
| Penumbra, Inc. (PEN)vs › | $12.57B | 0.11% | N/A | N/A | N/A |
| Baxter International Inc. (BAX)vs › | $12.45B | 0.49% | N/A | N/A | N/A |
| Encompass Health Corporation (EHC)vs › | $12.11B | 0.38% | N/A | N/A | N/A |
| Viatris Inc. (VTRS)vs › | $18.99B | 0.39% | N/A | N/A | N/A |
Debt/Assets
37.1%
Debt/Equity
1.10
Current Ratio
1.02
Interest Coverage
6.3x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 37.11% |
| 2026-03-31 | 36.04% |
| 2025-12-31 | 35.22% |
| 2025-09-30 | 36.76% |
| 2025-06-30 | 51.84% |
| 2025-03-31 | 54.47% |
| 2024-12-31 | 55.41% |
| 2024-09-30 | 54.99% |
| 2024-06-30 | 56.98% |
| 2024-03-31 | 56.44% |
| 2023-12-31 | 59.55% |
| 2023-09-30 | 60.01% |
| 2023-06-30 | 1.08% |
